Virtual screens could make augmented reality more useful during cardiac ablation

The use of augmented reality (AR) during cardiac ablation procedures may be improved by adding “virtual screens” that clinicians can customize as they see fit. That was the primary takeaway of a new analysis published in the Journal of Interventional Cardiac Electrophysiology.[1]

The study’s authors reviewed the potential of a new feature being developed for the CommandEP mixed reality system from St. Louis-based Sentiar. CommandEP provides real-time 3D digital images that appear via AR. This new feature adds up to five virtual screens to give the user’s AR environment a significant upgrade. It is still under development; this analysis examines the first use of the feature on animal models.

“During standard electrophysiology studies, physicians use multiple screens during the procedure, including electrograms (EGMs) (often live EGMs and review EGMs), intracardiac echocardiography, 3D electroanatomic mapping, mapping and fluoroscopy,” wrote first author Timothy R. Maher, MD, an electrophysiologist with Beth Israel Deaconess Medical Center, and colleagues. “In this new system, the data from these unique and discrete data sources are hard wired to an access point that wirelessly transmits the screen data to the head-mounted display. The virtual screen module allows users to create an individualized custom spatial layout of the chosen screens into virtual field of view.”

Subscribe to Cardiovascular Business News

Maher et al. reviewed feedback from ablation procedures performed with this new technology on animal models.   

“Post-testing survey questionnaires demonstrated high usability,” the authors wrote. “All users felt that the virtual screen module provided useful data during electrophysiology studies and liked the ability to arrange the screens as they wished. Additionally, there were no concerns about image quality from users who tested various inputs.”

Users also emphasized that gaining access to this technology “would be impactful to their practice.” 

Two of this small study’s co-authors are Sentiar representatives. However, the group declared that their research was conducted outside of any “commercial or financial relationships that could be construed as a potential conflict of interest.” 

Additional research will still be necessary to study how this technology may impact procedure lengths and patient outcomes. Similar features are being developed by other medtech companies, the group added. 

Click here for the full analysis.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Subscribe to Cardiovascular Business News

Subscribe to Cardiovascular Business News